FibroSURE(™) and FibroScan(®) in relation to treatment response in chronic hepatitis C virus

AIM: To compare histological endpoint assessment using noninvasive alternatives to biopsy during treatment in a chronic hepatitis C virus (HCV) cohort. METHODS: Patients with chronic HCV were randomized to receive interferon-based therapy for 24 (genotypes 2/3) or 48 (genotype 1) wk. FibroSURE™ (FS)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Patel, Keyur, Friedrich-Rust, Mireen, Lurie, Yoav, Grigorescu, Mircea, Stanciu, Carol, Lee, Chuan-Mo, Schiff, Eugene R, Häussinger, Dieter, Manns, Michael P, Gerken, Guido, Colle, Isabelle, Torbenson, Michael, Pulkstenis, Erik, Subramanian, G Mani, McHutchison, John G, Zeuzem, Stefan
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Co., Limited 2011
Sujets:
Brief Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225094/
https://ncbi.nlm.nih.gov/pubmed/22147963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i41.4581
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires